Sign in

CIK 0001444192

  • Non-accelerated filer
  • Smaller reporting company

Grace Therapeutics, Inc.

Sign in to watch
Ticker
GRCE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Mar 31
Incorporated
DE
Entity type
Operating
Phone
+1 609-322-1602
Business address
103 CARNEGIE CENTER, SUITE 300, PRINCETON, NJ, 08540
Former names
Acasti Pharma Inc.
Open-market buys, last 90 days
$898,410
in 12 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$898,410. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Opaleye Management Inc. +$684K 10% owner 11 filings
  2. Kohli Prashant +$214K Chief Executive Officer 1 filing
Date Insider Transaction Shares Price Value Owned after
2026-08-28 Kumar Amresh VP Program Management Grant or award · Stock Option (Right to Buy) +35,760 35,760
2025-04-14 Kumar Amresh VP Program Management Grant or award · Stock Option (Right to Buy) +30,000 30,000
2024-05-06 Kumar Amresh VP Program Management Grant or award · Stock Options (Right to Buy) +19,740 19,740
2024-05-06 Kumar Amresh VP Clinical Operations Grant or award · Stock Options (Right to Buy) +19,740 19,740
2023-07-14 Kumar Amresh VP Program Management Grant or award · Stock Options (Right to Buy) +42,000 42,000

Page 1 of 1 · 5 trades